Offer - Urjas Oil for just ₹ 1 X
Lopimune Tablet (30) is a prescription medicine that is available as a Capsule. Other than this, Lopimune Tablet (30) has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Lopimune Tablet (30). Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Lopimune Tablet (30) also has some side effects, the most common being Headache. While these are the most often observed Lopimune Tablet (30) side effects, there are can be others also. These have been listed below. Such side effects of Lopimune Tablet (30) normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Lopimune Tablet (30) has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Lopimune Tablet (30)'s effects on the liver, heart and kidney, if any, have been listed below.
Lopimune Tablet (30) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Lopimune Tablet (30) in conditions like Liver Disease, Hemophilia. The section on Lopimune Tablet (30) contraindications lists all such conditions.
Additionally, Lopimune Tablet (30) may also adversely react with other medicines. See below for a complete list.
You should also be aware that Lopimune Tablet (30) is not safe while driving, and is not addiction.
Lopimune Tablet (30) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Lopimune Tablet (30) safe for pregnant women?
Pregnant women may experience moderate side effects from Lopimune. It is best to stop taking Lopimune immediately and inform your doctor if you notice any discomfort.
Is the use of Lopimune Tablet (30) safe during breastfeeding?
Lopimune may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Lopimune, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Lopimune.
What is the effect of Lopimune Tablet (30) on the Kidneys?
Lopimune is not harmful for kidneys.
What is the effect of Lopimune Tablet (30) on the Liver?
Very few cases of side effects of Lopimune on the liver have been reported.
What is the effect of Lopimune Tablet (30) on the Heart?
Lopimune is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Lopimune Tablet (30) unless your doctor advises you to do so -
Is this Lopimune Tablet (30) habit forming or addictive?
Lopimune Tablet (30) is not addictive in nature.
Interaction between Food and Lopimune Tablet (30)
Some foods when eaten with Lopimune Tablet (30) can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Lopimune Tablet (30)
Taking alcohol with Lopimune Tablet (30) can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvir (ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 810
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 939-941
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Kaletra (lopinavir and ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 811